Table 2.
Comparison of clinical scale data between the TD and PIGD patients.
| Total | MH | |||||
|---|---|---|---|---|---|---|
| TD | PIGD | p | TD | PIGD | p | |
| UPDRS I | 2.23 ± 2.29 | 2.98 ± 2.11 | 0.004 | 2.68 ± 1.62 | 4.03 ± 2.05 | 0.012 |
| UPDRSII | 12.03 ± 6.10 | 13.53 ± 5.44 | 0.047 | 15.05 ± 7.19 | 13.95 ± 4.35 | 0.860 |
| UPDRSIV | 1.30 ± 2.15 | 2.09 ± 2.75 | 0.050 | 2.09 ± 2.49 | 2.26 ± 2.84 | 0.987 |
| HAMA | 6.01 ± 4.48 | 8.01 ± 4.74 | 0.002 | 7.50 ± 4.64 | 9.68 ± 4.54 | 0.080 |
| HAMD | 7.08 ± 4.85 | 9.60 ± 5.13 | <0.001 | 8.23 ± 4.20 | 11.26 ± 5.06 | 0.021 |
| MoCA | 24.20 ± 5.04 | 23.34 ± 5.93 | 0.333 | 24.36 ± 4.32 | 23.42 ± 5.75 | 0.700 |
| NMS-Quest | 10.36 ± 5.21 | 13.89 ± 5.15 | <0.001 | 13.18 ± 5.60 | 17.26 ± 4.40 | 0.003 |
| RBDSQ | 2.17 ± 2.04 | 3.86 ± 2.81 | <0.001 | 2.50 ± 2.52 | 5.16 ± 2.54 | <0.001 |
| PSQI | 6.80 ± 5.07 | 7.31 ± 4.56 | 0.361 | 7.77 ± 4.61 | 7.97 ± 4.75 | 0.874 |
| PDSS | 109.48 ± 27.62 | 108.63 ± 26.54 | 0.697 | 91.71 ± 27.09 | 100.52 ± 26.39 | 0.182 |
| PDQ39 | 39.0.12 ± 25.92 | 53.71 ± 26.34 | <0.001 | 46.91 ± 29.56 | 60.76 ± 26.47 | 0.066 |
Data are shown as mean ± SD; Bold data are statistically significant (p < 0.05). MH, minor hallucination; TD, tremor dominant; PIGD, postural instability and gait difficulty; UPDRS I, Unified Parkinson’s Disease Rating Scale part1; UPDRS II, Unified Parkinson’s Disease Rating Scale part 2; UPDRSIV, Unified Parkinson’s Disease Rating Scale part 4; HAMA, Hamilton Anxiety Rating Scale; HAMD, Hamilton Depression Rating Scale; MoCA, Montreal Cognitive Assessment; NMS-Quest, Non-Motor Symptoms Questionnaire; RBDSQ, the REM sleep behavior disorder Sreening Questionnaire; PSQI, Pittsburgh Sleep Quality Index; PDSS, Parkinson’s Disease Sleep Scale; PDQ39, Parkinson’s Disease Questionnaire-39.